Alto Neuroscience stock rises as firm secures $120M to advance depression drug

Alto's funding boost for depression drug trials could accelerate innovative treatments, potentially transforming neuropsychiatric care landscapes. The post Alto Neuroscience stock rises as firm sec...

By · · 1 min read
Alto Neuroscience stock rises as firm secures $120M to advance depression drug

Source: Crypto Briefing

Alto's funding boost for depression drug trials could accelerate innovative treatments, potentially transforming neuropsychiatric care landscapes. The post Alto Neuroscience stock rises as firm secures $120M to advance depression drug appeared first on Crypto Briefing.